About This EventHemab Therapeutics (Nasdaq: COAG), a clinical-stage biotechnology company developing therapies that reimagine ...

Key data is currently not available. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute.

About This EventInformation Services Group, Inc. (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm, visits the Nasdaq MarketSite in Times Square.In honor of the occasion, ...

About This EventFerrovial (Nasdaq: FER), a leading global infrastructure company, visits the Nasdaq MarketSite in Times ...

About This EventKymera Therapeutics, Inc. (Nasdaq: KYMR), a clinical-stage biopharmaceutical company advancing a new class of ...

Real time quote data is not available at this time.

Still, since the dips in the IPO Pulses fall well short of signaling a downturn in IPO activity and U.S. and European equities have rebounded in April, it’s entirely possible that the first quarter’s ...

About This EventAvalyn Pharma (Nasdaq: AVLN), visits the Nasdaq MarketSite in Times Square. The company is advancing ...

Historical Data is currently not available.

Nasdaq Data Link is a marketplace for financial, economic and alternative data delivered in modern formats for today's analysts, including Python, Excel. Nasdaq.com’s Dividend History page provides ...

Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute.

Nasdaq’s Q1 earnings report showed that the company delivered exceptional performance, with $1.4 billion in quarterly net revenue, an increase of 13% on an organic basis, and $1 ...